High Serum Urate Levels Associated With Poorer Health-Related Quality of Life Outcomes in Patients With Gout
Study authors evaluated the association between serum urate levels and health-related quality of life in patients with gout.
Study authors evaluated the association between serum urate levels and health-related quality of life in patients with gout.
Study authors examined the effect of gout diagnosis and flare on length of hospital stays in patients with heart failure exacerbation.
Study authors evaluated the diagnostic accuracy of dual-energy computed tomography vs ultrasound, or their combination, for the diagnosis of gout.
Researchers evaluated the efficacy and safety of the induction treatment with mycophenolate mofetil and cyclophosphamide for lupus nephritis.
Researchers evaluated opioid use disorder hospitalizations and associated healthcare utilization outcomes in patients with common musculoskeletal diseases.
Researchers evaluated the properties and locations of color-coded dual-energy lesions in patients with gout.
Patients with gout receiving urate lowering therapy by a treat-to-target approach demonstrate a reduced burden of monosodium urate crystals detected on ultrasound.
Researchers determined the association between gout and epilepsy and the risk for epilepsy in patients with gout.
Oral bisphosphonate treatment was not associated with increased all-cause mortality risk in patients with moderate to severe chronic kidney disease.
Older men receiving testosterone treatment with higher waist-to-hip ratio experience greater increases in noncalcified coronary plaque volume.